- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01591564
Interpersonal Psychotherapy in Youth With Severe Mood Dysregulation-Pilot
The purpose of this study is to determine the feasibility and acceptability of an utilizing an adapted form (IPT-SMD)of a psychosocial intervention, Interpersonal Psychotherapy for Depressed Adolescents, for youth with severe mood dysregulation (SMD).
The investigators hypothesize that retention rates will be >80%,satisfaction scores will average 6 (high) on a 7 point satisfaction scale, and that youth who receive the IPT-SMD intervention will have overall improvement in SMD symptoms.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- Johns Hopkins Bayview Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female subjects, ages 13 to 17 years, who meet criteria for severe mood dysregulation as defined by NIMH criteria.
- Subject has an estimated IQ >70 on the Kaufman Brief Intelligence Test (KBIT-2)
- Subjects will have continuously resided with a legal guardian who has known the adolescent well for at least one year before study entry and is legally able to sign the consent form.
- Participants must be on the same dose of any prescribed medication for 4 weeks prior to randomization.
- Children's Global Assessment Scale (CGAS) ≤ 60
Exclusion Criteria:
- Subject poses a significant risk for dangerousness to self or others. Risk will be determined by clinical history, clinical diagnostic interview and KSADS-PL interview of parent and patient by clinician.
- Subject suffers from a concomitant medical or psychiatric co-morbidity that makes this study protocol inadvisable (either the treatment is contraindicated or the disorder is not the primary focus of treatment).
- Subject meets DSM-IV criteria for current alcohol or substance dependence or current use (defined as the past 4 weeks).
- Pregnant females.
- Primary caretaker does not speak English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: therapy
All participants will receive the intervention.
|
Youth will receive weekly therapy sessions for 16 weeks and then bi-weekly session until week 20.
Parent sessions will also be included.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retention rate
Time Frame: 20 weeks
|
We are assessing the feasibility and acceptability of IPT-SMD in anticipation of conducting a larger trial.
|
20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Global Impressions Scale CGI-I (SMD)
Time Frame: 20 weeks
|
We will utilize the CGI-I (SMD) to assess the effectiveness of IPT-SMD on the severity of SMD symptoms in youth with SMD.
|
20 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Leslie Miller, M.D., Johns Hopkins University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NA_00046454
- K23MH090246 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Mood Dysregulation
-
Federal University of Rio Grande do SulUnknownSevere Mood DysregulationBrazil
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedSevere Mood DysregulationUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); ShireCompletedSevere Mood DysregulationUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
Tri-Service General HospitalMinistry of Science and Technology, TaiwanCompletedDisruptive Mood Dysregulation Disorder
-
VA Palo Alto Health Care SystemSeoul SemiconductorCompletedSleep | Mood | Circadian DysregulationUnited States
-
Centre Hospitalier Universitaire, AmiensRecruitingDisruptive Mood Dysregulation Disorder | Prognosis Factors | Suicidal Behaviors | ActigraphyFrance
-
Neuromotion LabsNational Institute of Mental Health (NIMH); Magellan HealthcareRecruiting
-
Karolinska InstitutetTerminatedEmotional DysregulationSweden
-
Centre Hospitalier Universitaire de BesanconCompleted
Clinical Trials on Interpersonal Psychotherapy for youth with SMD (IPT-SMD)
-
University of PittsburghCompletedDepression | Anxiety Disorders | Panic DisorderUnited States
-
New York State Psychiatric InstituteCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedDepression | Bipolar DisorderUnited States
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
Brown UniversityNational Institute of Mental Health (NIMH)CompletedMajor Depressive Disorder | Miscarriage | Stillbirth | Neonatal DeathUnited States
-
New York UniversityNational Institute of Mental Health (NIMH); Columbia UniversityRecruitingDepression | Suicidal IdeationUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
Linnaeus UniversityGöteborg University; Linkoeping UniversityRecruitingBulimia Nervosa | Major Depression | Anorexia Nervosa/BulimiaSweden
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH); University of Illinois at Urbana-Champaign and other collaboratorsCompleted